# Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study

> **NCT03709381** · EARLY_PHASE1 · COMPLETED · sponsor: **Nationwide Children's Hospital** · enrollment: 10 (actual)

## Conditions studied

- Adrenal Insufficiency
- Osteopenia, Osteoporosis
- Steroid Suppression of ACTH Secretion

## Interventions

- **DRUG:** Low Dose Cosyntropin (ACTH) stimulation test
- **DRUG:** High Dose Cosyntropin (ACTH) stimulation test

## Key facts

- **NCT ID:** NCT03709381
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2018-10-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709381, "Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03709381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
